Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13792097 | 0.89 | CALCRL (1.00) | CALCRLCYP3A4 | |
| SCHEMBL4228971 | 0.87 | CALCRL (1.00) | CALCRLCYP3A4 | |
| SCHEMBL4228977 | 0.87 | CALCRL (1.00) | CALCRLCYP3A4 | |
| SCHEMBL16846480 | 0.83 | CALCRL (0.79) | CALCRLCYP3A4 | |
| SCHEMBL4051284 | 0.83 | CALCRL (1.00) | CALCRLCYP3A4 | |
| SCHEMBL5108092 | 0.83 | CALCRL (1.00) | CALCRLCYP3A4 | |
| SCHEMBL4226199 | 0.83 | CALCRL (0.71) | CALCRLCYP3A4 | |
| SCHEMBL4226191 | 0.83 | CALCRL (0.71) | CALCRLCYP3A4 | |
| SCHEMBL3886335 | 0.83 | CALCRL (1.00) | CALCRLCYP3A4 | |
| SCHEMBL3884818 | 0.83 | CALCRL (1.00) | CALCRLCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080287422-A1 | Constrained Compounds as CGRP-Receptor Antagonists | BRISTOL-MYERS SQUIBB COMPANY | 2008-11-20 | — | — | US | disclosed |
| US-20080287422-A1 | Constrained Compounds as CGRP-Receptor Antagonists | BRISTOL-MYERS SQUIBB COMPANY | 2008-11-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080287422-A1 | Constrained Compounds as CGRP-Receptor Antagonists | CALCR, BDKRB2, CALCRL | CALCRL 3/4885CYP3A4 3221/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.